George H Conrades Oracle Corp (ORCL) insider trading activity

George H Conrades is Director of ORACLE CORP. Currently has a direct ownership of 21,139 shares of ORCL, which is worth approximately $4.01 Million. The most recent transaction as insider was on May 31, 2024, when has been sold 3,303 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 21.1K

0% 3M change

18.52% 12M change

Total Value Held $4.01 Million

GEORGE H CONRADES Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 31 2024	BUY Exercise of conversion of derivative security	-	3,303 Added 13.51%	21,139 Common Stock
May 03 2024	SELL Open market or private sale	$2,320,000 $116.0 p/Share	20,000 Reduced 52.86%	17,836 Common Stock
May 03 2024	BUY Exercise of conversion of derivative security	$840,400 $42.02 p/Share	20,000 Added 34.58%	37,836 Common Stock
May 01 2024	SELL Open market or private sale	$2,903,250 $116.13 p/Share	25,000 Reduced 58.36%	17,836 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$1,050,500 $42.02 p/Share	25,000 Added 36.85%	42,836 Common Stock
Nov 13 2023	SELL Open market or private sale	$264,492 $113.76 p/Share	2,325 Reduced 11.53%	17,836 Common Stock
Nov 10 2023	SELL Open market or private sale	$260,330 $111.97 p/Share	2,325 Reduced 10.34%	20,161 Common Stock
May 31 2023	BUY Exercise of conversion of derivative security	-	4,866 Added 17.79%	22,486 Common Stock
Dec 22 2022	SELL Bona fide gift	-	37,500 Reduced 68.03%	17,620 Common Stock
May 31 2022	BUY Exercise of conversion of derivative security	-	4,445 Added 7.46%	55,120 Common Stock
May 31 2021	BUY Exercise of conversion of derivative security	-	6,509 Added 11.38%	50,675 Common Stock
May 31 2020	BUY Exercise of conversion of derivative security	-	11,857 Added 21.16%	44,166 Common Stock
May 31 2019	BUY Exercise of conversion of derivative security	-	12,465 Added 27.84%	32,309 Common Stock
May 31 2018	BUY Exercise of conversion of derivative security	-	9,844 Added 33.16%	19,844 Common Stock
Sep 29 2017	SELL Open market or private sale	$2,171,250 $48.25 p/Share	45,000 Reduced 81.82%	10,000 Common Stock
Sep 29 2017	BUY Exercise of conversion of derivative security	$1,520,100 $33.78 p/Share	45,000 Added 45.0%	55,000 Common Stock
Sep 28 2017	SELL Open market or private sale	$541,125 $48.1 p/Share	11,250 Reduced 52.94%	10,000 Common Stock
Sep 22 2017	SELL Open market or private sale	$2,714,062 $48.25 p/Share	56,250 Reduced 72.58%	21,250 Common Stock
Sep 22 2017	BUY Exercise of conversion of derivative security	$1,707,188 $30.35 p/Share	56,250 Added 42.06%	77,500 Common Stock
May 31 2017	BUY Exercise of conversion of derivative security	-	9,844 Added 31.66%	21,250 Common Stock
May 31 2016	BUY Exercise of conversion of derivative security	-	1,406 Added 10.97%	11,406 Common Stock
Dec 21 2015	SELL Open market or private sale	$2,860,200 $36.32 p/Share	78,750 Reduced 88.73%	10,000 Common Stock
Dec 21 2015	BUY Exercise of conversion of derivative security	$1,930,950 $24.52 p/Share	78,750 Added 47.01%	88,750 Common Stock
Oct 30 2015	SELL Open market or private sale	$1,746,000 $38.8 p/Share	45,000 Reduced 81.82%	10,000 Common Stock
Oct 30 2015	BUY Exercise of conversion of derivative security	$881,550 $19.59 p/Share	45,000 Added 45.0%	55,000 Common Stock

Also insider at

CYCN

Cyclerion Therapeutics, Inc. Healthcare

GHC